November 23, 2014 8:42 AM ET


Company Overview of LXR Biotechnology Inc.

Company Overview

LXR Biotechnology, Inc. was engaged in the research and development of therapeutics to treat diseases caused by or associated with apoptosis, as of September 30, 1999. The company’s compounds included HK-Cardiosol™, CP-Cardiosol™, and Elirex™.

3095 Richmond Parkway

Suite 213

Richmond, CA 94806

United States

25 Employees



Key Executives for LXR Biotechnology Inc.

LXR Biotechnology Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Synedgen, Inc. United States
Liquidia Technologies, Inc. United States
Percipio Biotherapeutics, Inc. United States
RayBiotech, Inc. United States
NexGenix Pharmaceuticals Holdings, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LXR Biotechnology Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at